Piqray (alpelisib) - Novartis
Piqray: Regulatory approval in EU for HR+/HER2- advanced breast cancer in 2020 (Novartis) - Oct 14, 2019 - Kisqali MONALEESA-3 ESMO Data Investor Call 
European regulatory
https://www.novartis.com/sites/www.novartis.com/files/2019-10-novartis-esmo-investor-call-presentation.pdf
 
Oct 14, 2019
 
 
c27fe016-44c3-41c3-bb18-635c4891a68a.jpg